Taken together, these results suggested the prognosis‐related tumor antigens including IGF2BP3, DPCR1, HOXD10, TRIM7, and ZIC5 were promising targets of being developed as mRNA vaccines against COAD. Here, MUCL3 is linked to colon adenocarcinoma.